Specialty Pharmacy

Top news of the day from across the health care landscape.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses how to increase the utilization of biosimilars across the industry.

Researchers focus on generating a robust HIV-neutralizing antibody response.

Grape compounds may be an effective treatment option for colon cancer patients.

A specific immune T cell protects patients with lung cancer.

Clinical trial shows efficacy of Janus kinase inhibitor and methotrexate.

Mathematical model brings scientists a step closer to developing total viral suppression strategies among patients with HIV.

Sandoz has the highest number of biosimilars approved in Europe.

Some hair care products may cause increased cancer risk.

Waiting to get treatment for breast cancer results is worse survival outcomes.

Rheumatoid arthritis should be included to list of medical conditions linked to obesity.

Radioactive particles attack skin and increase the risk of skin cancer.

Patients with rheumatic and musculoskeletal disease can maintain a sustainable work life through educational programs.

Study will examine the safety and efficacy of tralokinumab monotherapy in treating atopic dermatitis.

Top news of the day from across the health care landscape.

High concentrations of phosphorylated Tau predict the development of cognitive problems in cancer survivors later in life.

Despite extensive research, there have been no new treatments in nearly 40 years for osteosarcoma.

HPV testing results in faster detection and treatment of cervical precancer.

Urinary cytomegalovirus shedding is a significant risk factor for CMV and HIV transmission.

Findings suggest an association between lower disease activity and a higher intake of fish.

New diagnoses and prevalence of HIV is illustrated by demographics, location, and social determinants of health.

A look at last week's top stories in the world of pharmacy.

Multilayer hydrogel cubes provide a potential solution for the poor solubility and low bioavailability of an anti-cancer drug.

HIV disproportionately affects blacks and Latinos, who are less likely to receive ongoing care.

CT-P10 is indicated to treat rheumatoid arthritis, non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, granulomatosis with polyangiitis, and microscopic polyangi.

Top articles of the week from Specialty Pharmacy Times.

Low testosterone found to increase the prevalence of chronic diseases among prostate cancer survivors.

Accumulation of gene mutations occurs in some patients with rheumatoid arthritis, study finds.